28 August 2025
: Case report 
Pancreatic Inflammation Induced by Immune Checkpoint Inhibitors in Melanoma Treatment: A Case Report
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy
Abdo I. El Tawil ABCDEF 1*, Beatriz A. Mendes ABCDEF 1, Leandro A.F. Machoski ABCDEF 1, Micheli F. Domingos AEF 2, Noelle S. Wassano AEF 3, Sérgio O. Ioshii AEF 4, Eduardo J.B. Ramos AEF 2DOI: 10.12659/AJCR.948580
Am J Case Rep 2025; 26:e948580
Figure 5 Axial section positron emission-computed tomography (PET-CT) demonstrates a small focus of mildly increased fluorodeoxyglucose uptake in the pancreatic body, with a maximum standardized uptake value of 2.3 (yellow crosshairs). The lesion shows no associated mass effect or surrounding inflammatory changes on the CT component. No additional hypermetabolic foci were identified in the pancreas or surrounding lymphatic chains.